Our top pick for
SunOpta Inc is a packaged foods business based in the US. SunOpta shares (STKL) are listed on the NASDAQ and all prices are listed in US Dollars. SunOpta employs 1,451 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$8.01|
|52-week range||$6.65 - $17.07|
|50-day moving average||$9.04|
|200-day moving average||$11.38|
|Wall St. target price||$18.80|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.68|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-14)||-4.98%|
|1 month (2021-09-21)||-8.67%|
|3 months (2021-07-21)||-27.45%|
|6 months (2021-04-21)||-42.87%|
|1 year (2020-10-21)||4.16%|
|2 years (2019-10-21)||437.58%|
|3 years (2018-10-19)||5.12%|
|5 years (2016-10-21)||23.42%|
Valuing SunOpta stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of SunOpta's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
SunOpta's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 12x. In other words, SunOpta shares trade at around 12x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
SunOpta's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 31.17. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into SunOpta's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
SunOpta's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $50.2 million.
The EBITDA is a measure of a SunOpta's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$807.1 million|
|Operating margin TTM||2.28%|
|Gross profit TTM||$111 million|
|Return on assets TTM||1.39%|
|Return on equity TTM||-12.8%|
|Market capitalisation||$875.1 million|
TTM: trailing 12 months
There are currently 1.2 million SunOpta shares held short by investors – that's known as SunOpta's "short interest". This figure is 11.6% up from 1.1 million last month.
There are a few different ways that this level of interest in shorting SunOpta shares can be evaluated.
SunOpta's "short interest ratio" (SIR) is the quantity of SunOpta shares currently shorted divided by the average quantity of SunOpta shares traded daily (recently around 578486.85446009). SunOpta's SIR currently stands at 2.13. In other words for every 100,000 SunOpta shares traded daily on the market, roughly 2130 shares are currently held short.
However SunOpta's short interest can also be evaluated against the total number of SunOpta shares, or, against the total number of tradable SunOpta shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case SunOpta's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 SunOpta shares in existence, roughly 10 shares are currently held short) or 0.0131% of the tradable shares (for every 100,000 tradable SunOpta shares, roughly 13 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against SunOpta.
Find out more about how you can short SunOpta stock.
We're not expecting SunOpta to pay a dividend over the next 12 months.
Over the last 12 months, SunOpta's shares have ranged in value from as little as $6.65 up to $17.065. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while SunOpta's is 2.2181. This would suggest that SunOpta's shares are significantly more volatile than the average for this exchange and represent a higher risk.
SunOpta Inc. manufactures and sells plant-based and fruit-based food and beverage products to retail customers, foodservice distributors, branded food companies, and food manufacturers worldwide. The company operates through two segments, Plant-Based Foods and Beverages, and Fruit-Based Foods and Beverages. The Plant-Based Foods and Beverages segment provides plant-based beverages, and liquid and dry ingredients that utilizes almond, soy, coconut, oat, hemp, and other bases, as well as broths, teas, and nutritional beverages. This segment also packages dry- and oil-roasted in-shell sunflower and sunflower kernels, as well as corn-, soy-, and legume-based roasted snacks; and processes and sells raw sunflower inshell and kernel for food and feed applications. The Fruit-Based Foods and Beverages segment offers individually quick frozen (IQF) fruits, such as strawberries, blueberries, mangos, pineapples, blends, and other berries for retail; and IQF and bulk frozen fruits, including purées, fruit cups, and smoothies for foodservice, and custom fruit preparations for industrial use. This segment also provides fruit snacks comprising bars, twists, ropes, and bite-sized products.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.